These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21139385)

  • 41. Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?
    Rutter P; Brown D; Howard J; Randall C
    Drug Saf; 2014 Jul; 37(7):465-9. PubMed ID: 24951945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients.
    Pai AB
    J Am Pharm Assoc (2003); 2015; 55(1):e15-23; quiz e24-5. PubMed ID: 25503987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nonprescription Drugs and Self-medication-Approach and Practice to Pharmaceutical Education].
    Watanabe K; Ohno N
    Yakugaku Zasshi; 2016; 136(7):931-2. PubMed ID: 27374952
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
    Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
    Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fostering Mixed-skill Pharmacists for Careers in Health Support Pharmacies-Education to Overcome the Barrier of Limited Occupational Expertise].
    Yamada M; Sakaguchi T; Tokuda K; Ouchi K; Sekine H; Murakami A; Takada N; Ijitsu T; Kogure K
    Yakugaku Zasshi; 2019; 139(4):539-543. PubMed ID: 30930384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
    Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
    Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The future of community pharmacy practice in South Africa in the light of the proposed new qualification for pharmacists: implications and challenges.
    Malangu N
    Glob J Health Sci; 2014 Aug; 6(6):226-33. PubMed ID: 25363125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ["Pharmacy 3.0" and the meaning of vital signs for pharmacists].
    Hazama K
    Yakugaku Zasshi; 2012; 132(1):17-20. PubMed ID: 22214574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel.
    Schwartzberg E; Nathan JP; Avron S; Marom E
    Isr J Health Policy Res; 2018 Dec; 7(1):59. PubMed ID: 30501624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient valuation of pharmacist services for self care with OTC medications.
    Hong SH; Spadaro D; West D; Tak SH
    J Clin Pharm Ther; 2005 Jun; 30(3):193-9. PubMed ID: 15896235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists.
    Davis SR; Durvasula S; Merhi D; Young PM; Traini D; Bosnic Anticevich SZ
    Int J Clin Pharm; 2016 Feb; 38(1):135-43. PubMed ID: 26560115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving the provision of OTC medication information in community pharmacies in Poland.
    Piecuch A; Makarewicz-Wujec M; Kozłowska-Wojciechowska M
    Int J Clin Pharm; 2017 Feb; 39(1):70-77. PubMed ID: 27905078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacists and technicians can enhance patient care even more once national policies, practices, and priorities are aligned.
    Maine LL; Knapp KK; Scheckelhoff DJ
    Health Aff (Millwood); 2013 Nov; 32(11):1956-62. PubMed ID: 24191086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community pharmacist perceptions of delivering post-hospital discharge Medicines Use Reviews for elderly patients.
    Rutter P; Ramsbottom H; Fitzpatrick R
    Int J Clin Pharm; 2017 Feb; 39(1):33-36. PubMed ID: 27905074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Survey on drug-related problems in Lithuania's pharmacies].
    Kubiliene L; Liukenskyte S; Savickas A; Jureniene K
    Medicina (Kaunas); 2006; 42(5):424-8. PubMed ID: 16778471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Team-based Medical Care for Cardiac Failure-The Pharmacist's Expected Role].
    Takahashi M
    Yakugaku Zasshi; 2016; 136(8):1137-9. PubMed ID: 27477732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.